The need for resource‐linked translational oncology in the management of neuroblastoma and other childhood malignancies in low‐ and middle‐income countries

Abstract

How to cite this article: Van Heerden J, Kruger M. The need for resource-linked translational oncology in the management of neuroblastoma and other childhood malignancies in lowand middle-income countries. Pediatr Blood Cancer.

Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al

“…In fact, research studies addressing setting-relevant questions need to be performed also in low-income and middle-income countries. 5 Understandably, there is urgency for identifying alternatives to sargramostim for clinical use outside of North America, but we urge caution in using G-CSF as an alternative without further study, as these agents are not interchangeable. Healthcare providers need to continue to advocate for our patients and focus on the goal of providing affordable access to the most effective therapies for all patients with high-risk neuroblastoma.…”

“…In fact, research studies addressing setting-relevant questions need to be performed also in low-income and middle-income countries. 5 …”